35 related articles for article (PubMed ID: 7750217)
21. Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases.
Wiering B; Ruers TJ; Oyen WJ
Expert Rev Anticancer Ther; 2004 Aug; 4(4):607-13. PubMed ID: 15270664
[TBL] [Abstract][Full Text] [Related]
22. [Influence of positron emission tomography on surgical therapy planning in recurrent colorectal cancer].
Schlag PM; Amthauer H; Stroszczynski C; Felix R
Chirurg; 2001 Sep; 72(9):995-1002. PubMed ID: 11594285
[TBL] [Abstract][Full Text] [Related]
23. Correlative imaging with monoclonal antibodies in colorectal, ovarian, and prostate cancer.
Neal CE; Meis LC
Semin Nucl Med; 1994 Oct; 24(4):272-85. PubMed ID: 7817200
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies in ovarian and prostate cancer.
Neal CE; Swenson LC; Fanning J; Texter JH
Semin Nucl Med; 1993 Apr; 23(2):114-26. PubMed ID: 8511599
[TBL] [Abstract][Full Text] [Related]
25. New radiopharmaceuticals and new applications in medicine.
Teates CD; Parekh JS
Curr Probl Diagn Radiol; 1993; 22(6):229-66. PubMed ID: 8269717
[TBL] [Abstract][Full Text] [Related]
26. Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations.
Bohdiewicz PJ; Scott GC; Juni JE; Fink-Bennett D; Wilner F; Nagle C; Dworkin HJ
Clin Nucl Med; 1995 Mar; 20(3):230-6. PubMed ID: 7750217
[TBL] [Abstract][Full Text] [Related]
27. Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature.
Pinkas L; Robins PD; Forstrom LA; Mahoney DW; Mullan BP
Nucl Med Commun; 1999 Aug; 20(8):689-96. PubMed ID: 10451876
[TBL] [Abstract][Full Text] [Related]
28. OncoScint CR103 imaging in the surgical management of patients with colorectal cancer.
Doerr RJ; Abdel-Nabi HH
Targeted Diagn Ther; 1992; 6():89-109. PubMed ID: 1576352
[No Abstract] [Full Text] [Related]
29. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.
Wiering B; Krabbe PF; Jager GJ; Oyen WJ; Ruers TJ
Cancer; 2005 Dec; 104(12):2658-70. PubMed ID: 16315241
[TBL] [Abstract][Full Text] [Related]
30. Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.
Laurens ST; Oyen WJ
PET Clin; 2015 Jul; 10(3):345-60. PubMed ID: 26099671
[TBL] [Abstract][Full Text] [Related]
31. Multicenter clinical trials of monoclonal antibody B72.3-GYK-DTPA 111In (111In-CYT-103; OncoScint CR103) in patients with colorectal carcinoma.
Abdel-Nabi HH; Doerr RJ
Targeted Diagn Ther; 1992; 6():73-88. PubMed ID: 1576351
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
